Development and Validation of LC-Q-TOF-MS Methodology to Determine Mycotoxin Biomarkers in Human Urine.

MLA

Dasí-Navarro, Nuria, et al. “Development and Validation of LC-Q-TOF-MS Methodology to Determine Mycotoxin Biomarkers in Human Urine.” Toxins, vol. 14, no. 10, Sept. 2022. EBSCOhost, https://doi.org/10.3390/toxins14100651.

APA

Dasí-Navarro, N., Lozano, M., Llop, S., Esplugues, A., Cimbalo, A., Font, G., Manyes, L., Mañes, J., & Vila-Donat, P. (2022). Development and Validation of LC-Q-TOF-MS Methodology to Determine Mycotoxin Biomarkers in Human Urine. Toxins, 14(10). https://doi.org/10.3390/toxins14100651

Chicago

Dasí-Navarro, Nuria, Manuel Lozano, Sabrina Llop, Ana Esplugues, Alessandra Cimbalo, Guillermina Font, Lara Manyes, Jordi Mañes, and Pilar Vila-Donat. 2022. “Development and Validation of LC-Q-TOF-MS Methodology to Determine Mycotoxin Biomarkers in Human Urine.” Toxins 14 (10). doi:10.3390/toxins14100651.